Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus
A growing corpus of evidence implicates the involvement of the commensal microbiota and immune cytokines in the initiation and progression of systemic lupus erythematosus (SLE). Glucocorticoids have been widely used in the treatment of SLE patients, however, glucocorticoid treatment carries a higher...
Main Authors: | Mengchen Guo, Huixia Wang, Sixie Xu, Yaoyao Zhuang, Jingang An, Chuan Su, Yankai Xia, Jingyun Chen, Zhenjiang Zech Xu, Qisha Liu, Jianwei Wang, Zhou Dan, Kun Chen, Xiaoting Luan, Zhi Liu, Kangjian Liu, Faming Zhang, Yumin Xia, Xingyin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-11-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19490976.2020.1768644 |
Similar Items
-
Reversible dysregulation of renal circadian rhythm in lupus nephritis
by: Rakesh Mishra, et al.
Published: (2021-09-01) -
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
by: Marie Burns, et al.
Published: (2021-02-01) -
The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases
by: Haijing Wu, et al.
Published: (2019-09-01) -
Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
by: Jacqueline K. Flynn, et al.
Published: (2019-07-01) -
Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus
by: Haijing Wu, et al.
Published: (2016-12-01)